UK Funding Agency Apologizes for Role in Researchfish Controversy

Researchfish is a platform commonly used to track the status of grants and the impacts of research. When academics were critical of the company online, Researchfish shared these comments with the largest funding agency in the UK, and the scientists’ comments were sometimes shared with their employers.

Written byNatalia Mesa, PhD
| 3 min read
Smartphone with thumb over twitter icon
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The funding agency UK Research and Innovation has apologized to academics after admitting that it encouraged the research tracking company Researchfish to report critical comments made by academics regarding Researchfish’s software to UKRI. The agency, in turn, shared some of these comments with the academics’ employers.

In early March of this year, Researchfish, a company that helps universities and funders measure research impact, began tweeting at multiple researchers that it was sharing their complaints about the service with funding agencies. Many of those targeted by Researchfish had criticized the platform on Twitter for being cumbersome and time-consuming, reports Chemistry World. In response, the company tweeted to several scholars, stating that “we understand that you’re not keen on reporting on your funding through Researchfish but this seems quite harsh and inappropriate. We have shared our concerns with your funder.” Hundreds of academics took to Twitter to express their outrage, accusing Researchfish ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A black and white headshot

    As she was completing her graduate thesis on the neuroscience of vision, Natalia found that she loved to talk to other people about how science impacts them. This passion led Natalia to take up writing and science communication, and she has contributed to outlets including Scientific American and the Broad Institute. Natalia completed her PhD in neuroscience at the University of Washington and graduated from Cornell University with a bachelor’s degree in biological sciences. She was previously an intern at The Scientist, and currently freelances from her home in Seattle. 

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies